Significance of interleukin-6 (IL-6) in breast cancer (review).
about
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelHER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesisActivation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growthTumor self-seeding by circulating cancer cellsIL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary glandMutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomasBreast cancer survival among young women: a review of the role of modifiable lifestyle factorsChemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKCζAdipose tissue immunity and cancerMinireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancersInflammatory breast cancer: New factors contribute to disease etiology: A reviewBioTCM-SE: a semantic search engine for the information retrieval of modern biology and traditional Chinese medicineAnchorage-independent growth of breast carcinoma cells is mediated by serum exosomesSTAT3 can be activated through paracrine signaling in breast epithelial cells.Smartphone instrument for portable enzyme-linked immunosorbent assays.Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins.Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells.Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.The influence of tumor necrosis factor-α on the tumorigenic Wnt-signaling pathway in human mammary tissue from obese women.Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors.Improving gene expression data interpretation by finding latent factors that co-regulate gene modules with clinical factors.Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.Day-to-day dynamics of associations between sleep, napping, fatigue, and the cortisol diurnal rhythm in women diagnosed as having breast cancerIL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular developmentA signal transducer and activator of transcription 3·Nuclear Factor κB (Stat3·NFκB) complex is necessary for the expression of fascin in metastatic breast cancer cells in response to interleukin (IL)-6 and tumor necrosis factor (TNF)-αThe cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees.Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantationFOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays.Role of Notch and its oncogenic signaling crosstalk in breast cancer.Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55.Bone Morphogenetic Proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasionThe anti-cancer property of proteins extracted from Gynura procumbens (Lour.) Merr.The role of cytokines in breast cancer development and progressionClinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.
P2860
Q21090788-F9EBECC1-249F-434E-B5AD-1FDBF4066457Q24598092-0AFB583E-4919-4377-B144-800A946B43A0Q24620395-DA71590A-7A66-4A5D-BE83-625E3A338CB9Q24658224-9CEC283D-0F27-49DA-9438-3CFABC7AFE98Q24669531-34A8282B-D8E3-4403-895E-989513A5BF9DQ24669579-0B3A1C0E-041B-47C8-BF91-0FF3E0F1C32BQ26766205-61B7A9B1-7C3B-491F-8AEC-6727F76D77D3Q26853683-7920461C-549F-4723-A953-4ADA237926F6Q26862654-7D72ADAF-1763-4F52-BC35-AE9C8E5A15C0Q27016106-9F0DCA88-BA96-4A53-8A69-B104294ED73BQ27027856-081ECEDC-1935-4EDE-845A-0F19B088794EQ28659942-D1111D0C-F04B-4B5B-94EE-F105FE589268Q30438618-536E562A-FB69-431B-BF3B-9D67000F1BBDQ30849602-BB5FECDA-3464-4ABF-AD61-17A3C9D88508Q33442137-B67FD7D2-A930-4807-ACC0-E55FDAD91DEEQ33546544-C0BE791E-8C96-47DE-B31C-8CDA63723897Q33588841-E86BFC78-AC67-4696-8BCA-413FDAA6FD9FQ33634646-A0B6BDCD-69E9-45CB-A8DB-4EFE61C41435Q33686729-05F2674F-804C-42B1-A6DD-7D57CCBC8DAEQ33705238-88F9AACC-73A1-4F56-B749-36B97696536CQ33773047-C1085FCF-7C82-4B1E-8CC5-74AF28191896Q33829425-DDBBA564-6865-4A33-BEF5-CCB54E6ACFA3Q33959754-AFE488F9-0196-43C8-BE10-AC185C4D45C3Q34075869-0DDE9A8A-3FE7-4402-AA28-A1F33B10AC23Q34096100-A4D41538-0224-4574-8CF5-37A2EFCF7C79Q34175355-65F689BD-34F2-4419-B341-A48AB30060B9Q34346672-22F236C5-AE4C-4139-AA6C-67A56B80E8DBQ34355992-9E9E14F7-8965-42D8-AE67-6812421FE6A4Q34396993-65BCC24F-1351-450B-9A24-2871761300CCQ34467457-8C34E816-F8A4-42A6-BD64-343F48ADD37AQ34494526-8DDA7201-E1B7-4403-A16D-BEE056CF6879Q34618829-13A1CEFA-929F-4056-8826-F99B27AD37ECQ34660488-663F0E77-7FF7-4F9A-9AB6-AFAAC3D01253Q34669402-48BCA1EA-1029-4835-A3EC-F47D8077CE94Q34697373-98AEE010-88FA-45EF-A86F-7911EF9F18ADQ34769802-533B5557-D1CE-46F0-B1A9-6BB496D5F06BQ34807620-A88AEA17-C101-481C-A28A-1540690CD8B9Q34849136-FE1B3053-A315-4932-9B79-BC59D3D039F8Q34920381-20E73113-F74A-495E-9F43-C0F373E8D340Q35003674-5B39CEFC-1CD5-407C-AADB-1194AF540D4B
P2860
Significance of interleukin-6 (IL-6) in breast cancer (review).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Significance of interleukin-6 (IL-6) in breast cancer (review).
@ast
Significance of interleukin-6 (IL-6) in breast cancer (review).
@en
type
label
Significance of interleukin-6 (IL-6) in breast cancer (review).
@ast
Significance of interleukin-6 (IL-6) in breast cancer (review).
@en
prefLabel
Significance of interleukin-6 (IL-6) in breast cancer (review).
@ast
Significance of interleukin-6 (IL-6) in breast cancer (review).
@en
P1476
Significance of interleukin-6 (IL-6) in breast cancer (review).
@en
P2093
Heike Knüpfer
Rainer Preiss
P2888
P304
P356
10.1007/S10549-006-9328-3
P407
P577
2006-08-23T00:00:00Z